CUSIP NO. 58404W109 SCHEDULE 13G PAGE 1 OF 10 PAGES






===============================================================================

 UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
 WASHINGTON, D.C. 20549

 SCHEDULE 13G

 Under the Securities Exchange Act of 1934
 (Amendment No.)


 MedCath Corporation
-------------------------------------------------------------------------------
 (Name of Issuer)


 Common Stock, $0.01 par value
-------------------------------------------------------------------------------
 (Title of Class of Securities)


 58404W109
-------------------------------------------------------------------------------
 (CUSIP Number)


 October 3, 2011
-------------------------------------------------------------------------------
 (Date of Event Which Requires Filing of This Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
 [ ] Rule 13d-1(b)
 [X] Rule 13d-1(c)
 [ ] Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).

Information regarding beneficial ownership is as of October 13, 2011.


CUSIP NO. 58404W109 SCHEDULE 13G PAGE 2 OF 10 PAGES

--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON/S.S. OR I.R.S. IDENTIFICATION
 NO. OF ABOVE PERSON

 WEISS ASSET MANAGEMENT LP
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [ ]
 (B) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY


--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION

 DELAWARE
--------------------------------------------------------------------------------
 5. SOLE VOTING POWER

 0
 NUMBER OF --------------------------------------------------
 SHARES 6. SHARED VOTING POWER
 BENEFICIALLY
 OWNED BY 1,137,000
 EACH --------------------------------------------------
 REPORTING 7. SOLE DISPOSITIVE POWER
 PERSON
 WITH: 0
 --------------------------------------------------
 8. SHARED DISPOSITIVE POWER

 1,137,000
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 1,137,000
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
 CERTAIN SHARES* [ ]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 5.56%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*

 PN - Limited Partnership


CUSIP NO. 58404W109 SCHEDULE 13G PAGE 3 OF 10 PAGES

--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON/S.S. OR I.R.S. IDENTIFICATION
 NO. OF ABOVE PERSON

 WAM GP LLC
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [ ]
 (B) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY


--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION

 DELAWARE
--------------------------------------------------------------------------------
 5. SOLE VOTING POWER

 0
 NUMBER OF --------------------------------------------------
 SHARES 6. SHARED VOTING POWER
 BENEFICIALLY
 OWNED BY 1,137,000
 EACH --------------------------------------------------
 REPORTING 7. SOLE DISPOSITIVE POWER
 PERSON
 WITH: 0
 --------------------------------------------------
 8. SHARED DISPOSITIVE POWER

 1,137,000
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 1,137,000
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
 CERTAIN SHARES* [ ]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 5.56%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*

 00 - Limited Liability Company


CUSIP NO. 58404W109 SCHEDULE 13G PAGE 4 OF 10 PAGES

--------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON/S.S. OR I.R.S. IDENTIFICATION
 NO. OF ABOVE PERSON

 ANDREW M. WEISS
--------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (A) [ ]
 (B) [ ]
--------------------------------------------------------------------------------
3. SEC USE ONLY


--------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION

 USA
--------------------------------------------------------------------------------
 5. SOLE VOTING POWER

 0
 NUMBER OF --------------------------------------------------
 SHARES 6. SHARED VOTING POWER
 BENEFICIALLY
 OWNED BY 1,137,000
 EACH --------------------------------------------------
 REPORTING 7. SOLE DISPOSITIVE POWER
 PERSON
 WITH: 0
 --------------------------------------------------
 8. SHARED DISPOSITIVE POWER

 1,137,000
--------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 1,137,000
--------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
 CERTAIN SHARES* [ ]
--------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 5.56%
--------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*

 IN


CUSIP NO. 58404W109 SCHEDULE 13G PAGE 5 OF 10 PAGES

ITEM 1.
 (a) Name of Issuer: MedCath Corporation
 -----------------------------------

 (b) Address of Issuer's Principal Executive Offices:

 10720 Sikes Place, Suite 300
 Charlotte, North Carolina 28277
 --------------------------------
ITEM 2.

 (a) and (c): Name and Citizenship of Persons Filing:

 (i) WAM GP LLC, a Delaware limited liability company ("WAM GP")
 (ii) Weiss Asset Management LP, a Delaware limited partnership ("Weiss
 Asset Management").
 (iii) Andrew M. Weiss, a United States citizen ("Andrew Weiss").


 (b): Address of Principal Business Office:

 WAM GP, Weiss Asset Management, and Andrew Weiss have a business
 address of 222 Berkeley St., 16[th] Floor, Boston, Massachusetts 02116

 (d) Title of Class of Securities: Common Stock, $0.01 par value
 ---------------------------------

 (e) CUSIP Number: 58404W109
 ------------------

ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR 13D-2(B), CHECK
 WHETHER THE PERSON FILING IS A:

 (a) [ ] Broker or Dealer registered under Section 15 of the Act
 (15 U.S.C. 78o).
 (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
 (c) [ ] Insurance Company as defined in section 3(a)(19) of the Act
 (15 U.S.C. 78c).
 (d) [ ] Investment Company registered under section 8 of the Investment
 Company Act of 1940 (15 U.S.C. 80a-8).
 (e) [ ] Investment Adviser registered under section 203 of the Investment
 Advisers Act or under the laws of any State
 (f) [ ] Employee Benefit Plan, Pension fund which is subject to the
 provisions of the Employee Retirement Income Security Act of
 1974 or Endowment Fund; see Section 240.13d-1(b)(1)(ii)(F)
 (g) [ ] A Parent Holding Company or control person, in accordance with
 Section 240.13d-1(b)(ii)(G)(Note: See Item 7)
 (h) [ ] A Savings Association as defined in Section 3(b) of the Federal
 Deposit Insurance Act (12 U.S.C. 1813)
 (i) [ ] A Church Plan that is excluded from the definition of an
 investment company under Section 3(c)(14) of the Investment
 Company Act of 1940 (15 U.S.C. 80a-3)


CUSIP NO. 58404W109 SCHEDULE 13G PAGE 6 OF 10 PAGES

 (j) [ ] Group, in accordance with Section 240.13d-1(b)(1)(ii)(J)

ITEM 4. OWNERSHIP
 Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in Item I.

 WAM GP*
 (a) Amount Beneficially Owned: 1,137,000
 -------------------------------------------
 (b) Percent of Class: 5.56%
 ----------------------------------------------------
 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0
 ------------------------
 (ii) shared power to vote or to direct the vote: 1,137,000
 ------------------------
 (iii)sole power to dispose or to direct the disposition of: 0
 -----------
 (iv) shared power to dispose or to direct the disposition of: 1,137,000
 ---------

 WEISS ASSET MANAGEMENT*
 (a) Amount Beneficially Owned: 1,137,000
 -------------------------------------------
 (b) Percent of Class: 5.56%
 ----------------------------------------------------
 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0
 ------------------------
 (ii) shared power to vote or to direct the vote: 1,137,000
 -----------------------
 (iii)sole power to dispose or to direct the disposition of: 0
 -----------
 (iv) shared power to dispose or to direct the disposition of: 1,137,000
 ---------


CUSIP NO. 58404W109 SCHEDULE 13G PAGE 7 OF 10 PAGES


 ANDREW WEISS*
 (a) Amount Beneficially Owned: 1,137,000
 -------------------------------------------
 (b) Percent of Class: 5.56%
 ----------------------------------------------------
 (c) Number of shares as to which such person has:

 (i) sole power to vote or to direct the vote: 0
 ------------------------
 (ii) shared power to vote or to direct the vote: 1,137,000
 ------------------------
 (iii)sole power to dispose or to direct the disposition of: 0
 -----------
 (iv) shared power to dispose or to direct the disposition of: 1,137,000
 ---------
-----------------------
* Weiss Asset Management is the sole investment manager to a private investment
partnership (the "Partnership") and a private investment company (the
"Company"). WAM GP is the sole general partner of Weiss Asset Management.
Andrew Weiss is the managing member of WAM GP. Shares reported for WAM GP,
Andrew Weiss and Weiss Asset Management include shares beneficially owned by the
Partnership and the Company.

Each of WAM GP, Weiss Asset Management and Andrew Weiss disclaims beneficial
ownership of the shares reported herein as beneficially owned by each except to
the extent of their respective pecuniary interest therein. The percent of class
computations are based on 20,436,291 shares of Common Stock, $0.01 par value
outstanding as of August 5, 2011 as reported on the Form 10-Q filed with the SEC
on August 9, 2011.













PAGE>
CUSIP NO. 58404W109 SCHEDULE 13G PAGE 8 OF 10 PAGES

ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

 If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following [].


ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

 Not Applicable



ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
 SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL
 PERSON

 Not Applicable



ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP

 Not Applicable



ITEM 9. NOTICE OF DISSOLUTION OF GROUP

 Not Applicable


CUSIP NO. 58404W109 SCHEDULE 13G PAGE 9 OF 10 PAGES

ITEM 10. CERTIFICATION

By signing below, I certify that, to the best of my knowledge and belief, the
securities referred to above were not acquired and are not held for the purpose
of or with the effect of changing or influencing the control of the issuer of
the securities and were not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.


ITEM 11. MATERIALS TO BE FILED AS EXHIBITS

Exhibit 1 Joint Filing Agreement



 SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I hereby
certify that the information set forth in this statement is true, complete and
correct.

Dated: October 13, 2011


 WEISS ASSET MANAGEMENT LP


 By: /s/ Georgiy Nikitin
 -----------------------------------
 Georgiy Nikitin, Chief Compliance Officer


 WAM GP LLC


 By: /s/ Georgiy Nikitin
 -----------------------------------
 Georgiy Nikitin, Chief Compliance Officer


 ANDREW M. WEISS


 By: /s/ Georgiy Nikitin
 -----------------------------------
 Georgiy Nikitin, Attorney in Fact for Andrew M. Weiss


CUSIP NO. 58404W109 SCHEDULE 13G PAGE 10 OF 10 PAGES

 Exhibit 1

 JOINT FILING AGREEMENT

 In accordance with Rule 13d-1(k) under the Securities Exchange Act of
1934, as amended, WAM GP LLC, Weiss Asset Management LP and Andrew M. Weiss,
hereby agree to the joint filing on behalf of each of them of a statement on
Schedule 13G and/or 13D (including any and all amendments thereto) with respect
to the Common Stock of MedCath Corporation, and further agree that this Joint
Filing Agreement, as may be amended from time to time, shall be included as an
Exhibit to such joint filings.

 The undersigned further agree that each party hereto is responsible for
the timely filing of such Statement on Schedule 13G and/or 13D and any
amendments thereto, and for the accuracy and completeness of the information
concerning such party contained therein; provided, however, that no party is
responsible for the accuracy or completeness of the information concerning any
other party, unless such party knows or has reason to believe that such
information is inaccurate.

 This Joint Filing Agreement may be signed in counterparts with the same
effect as if the signature on each counterpart were upon the same instrument.

 IN WITNESS WHEREOF, the undersigned have executed this Agreement as of
October 13, 2011.




 WEISS ASSET MANAGEMENT LP

 By: /s/ Georgiy Nikitin
 -----------------------------------
 Georgiy Nikitin, Chief Compliance Officer


 WAM GP LLC

 By: /s/ Georgiy Nikitin
 -----------------------------------
 Georgiy Nikitin, Chief Compliance Officer


 ANDREW M. WEISS

 By: /s/ Georgiy Nikitin
 -----------------------------------
 Attorney-in-Fact for Andrew M. Weiss

Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Medcath Charts.
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Medcath Charts.